Crossmark

Targeting pre-miR-21 with β-Sitosterol to Inhibit miR-21-3p Maturation in Triple-Negative Breast Cancer: Structural and Comparative Insights with Doxorubicin

Crossref DOI link: https://doi.org/10.1007/s12247-026-10699-4

Published Online: 2026-04-25

Published Print: 2026-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Javadi, Sholeh https://orcid.org/0009-0008-2246-980X
Farahmand, Somayeh https://orcid.org/0000-0003-4075-925X
HajiHosseini, Reza https://orcid.org/0000-0003-0953-233X
Nasri, Sima https://orcid.org/0000-0001-7849-6315
License Information

Text and Data Mining valid from 2026-04-25

Version of Record valid from 2026-04-25
More Information

Article History

Received: 31 December 2025

Accepted: 13 April 2026

First Online: 25 April 2026

Declarations

:

: This study did not involve human participants or clinical samples; therefore, informed consent was not required and is not applicable to this work.

: Humans Statement: not applicable; Animals Statement: not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below